Active Recombinant Mouse Il11ra1, Fc Chimera

• Cat.No.: Il11ra1-701M
• Product Overview: Recombinant Mouse Il11ra1 (Accession # NP_001156873) was produced in Mouse myeloma cell line, NS0-derived.

Specification

• Source: Mammalian cells
• Species: Mouse
• Tag: Fc
• Predicted N Terminal: Cys26
• Form: Lyophilized from a 0.2 µm filtered solution in PBS.
• Bio-activity: Measured in a cell proliferation assay using T11 mouse plasmacytoma cells. Nordan, R.P. et al. (1987) J. Immunol. 139:813.The ED50 for this effect is typically 0.5-2 µg/mL in the presence of 0.75 ng/mL Recombinant Mouse IL-11
• Molecular Mass: Recombinant Mouse Il11ra1, Fc Chimera has a calculated MW of 64.6 kDa (monomer). In SDS-PAGE migrates as 75-80 kDa, reducing conditions.
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).

Gene Information

• Gene Name: Il11ra1 interleukin 11 receptor, alpha chain 1 [ Mus musculus ]
• Official Symbol: Il11ra1
• Synonyms: IL11RA1; interleukin 11 receptor, alpha chain 1; interleukin-11 receptor subunit alpha-1; NR-1; etl-2; locus 2; IL-11RA1; Il-11ra-alpha; IL-11R-alpha-1; IL-11R subunit alpha-1; novel cytokine receptor 1; enhancer trap locus homolog 2; IL-11 receptor subunit alpha-1; interleukin 11 receptor, alpha chain 2; NR1; GP130; Il11ra; Il-11ra; Il11ra2; AI314697
• Gene ID: 16157
• mRNA Refseq: NM_001163401
• Protein Refseq: NP_001156873

Reviews

08/14/2021

Good for cytokine assays.

02/01/2021

Effective in signaling studies.

01/09/2019

Consistent bioactivity.

Q&As

What are the advanced imaging techniques used to visualize the dynamic conformational changes of IL11RA1 upon ligand binding?

Advanced imaging techniques visualize IL11RA1 conformational changes upon ligand binding.

Can you elaborate on the utilization of animal models and transgenic approaches to study the tissue-specific functions of IL11RA1?

Animal models and transgenics study IL11RA1's tissue-specific functions.

How do reporter gene assays help in studying the transcriptional regulation of IL11RA1 gene expression?

Reporter gene assays study IL11RA1 gene expression regulation.

Can you explain the role of high-throughput screening in identifying small molecules that modulate IL11RA1 activity?

High-throughput screening identifies small molecules modulating IL11RA1 activity.

What insights have functional genomics studies provided regarding the role of IL11RA1 in disease pathogenesis?

Functional genomics unveil IL11RA1's role in disease pathogenesis.

How does site-directed mutagenesis contribute to understanding the binding interface between IL11RA1 and IL11?

Site-directed mutagenesis reveals the binding interface of IL11RA1 and IL11.

What methodologies like fluorescence resonance energy transfer (FRET) elucidate the intracellular signaling pathways activated by IL11RA1?

Fluorescence resonance energy transfer (FRET) reveals IL11RA1 signaling pathways.

How are biophysical methods such as circular dichroism (CD) spectroscopy employed to investigate the secondary structure changes of IL11RA1?

Circular dichroism (CD) spectroscopy probes IL11RA1 secondary structure changes.

How do proteomic analyses contribute to identifying IL11RA1-interacting proteins and potential signaling complexes?

Proteomics identifies IL11RA1-interacting proteins and signaling complexes.

What strategies like surface plasmon resonance (SPR) aid in quantifying the binding kinetics between IL11RA1 and its downstream effectors?

Surface plasmon resonance (SPR) quantifies IL11RA1 binding kinetics.